ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Rockwell Medical Inc

Rockwell Medical Inc (RMTI)

2.13
-0.05
(-2.29%)
Closed December 08 4:00PM
2.12
-0.01
(-0.47%)
After Hours: 7:52PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.12
Bid
2.12
Ask
2.19
Volume
599,597
2.11 Day's Range 2.18
1.16 52 Week Range 5.15
Market Cap
Previous Close
2.18
Open
2.17
Last Trade
31
@
2.12
Last Trade Time
Financial Volume
$ 1,283,300
VWAP
2.1403
Average Volume (3m)
765,738
Shares Outstanding
32,318,806
Dividend Yield
-
PE Ratio
-8.16
Earnings Per Share (EPS)
-0.26
Revenue
83.61M
Net Profit
-8.44M

About Rockwell Medical Inc

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic. Triferic is a therapy ind... Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. The company operates in one segment of the hemodialysis market which involves the exports, manufacture, sale, and distribution of hemodialysis products. Key revenue is generated from the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Electromedical Apparatus
Headquarters
Wilmington, Delaware, USA
Founded
2012
Rockwell Medical Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RMTI. The last closing price for Rockwell Medical was $2.18. Over the last year, Rockwell Medical shares have traded in a share price range of $ 1.16 to $ 5.15.

Rockwell Medical currently has 32,318,806 shares outstanding. The market capitalization of Rockwell Medical is $70.45 million. Rockwell Medical has a price to earnings ratio (PE ratio) of -8.16.

RMTI Latest News

Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...

Rockwell Medical Expands Distribution in the Philippines

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...

Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter

Reports net product sales of $28.3 million for the third quarter of 2024, an increase of 31% over net product sales for the same period in 2023. Net product sales for the third quarter of 2024...

Tesla Rises 5% Pre-Market After Surpassing $1T Market Value; U.S. Bans TSMC From Selling Advanced Chips to China

Tesla (NASDAQ:TSLA) – On Friday, Tesla’s market capitalization surpassed $1 trillion following Donald Trump’s election, anticipated to support CEO Elon Musk’s business ventures, as he...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.15-6.607929515422.272.292.126059332.22141633CS
4-2.28-51.81818181824.45.152.1213277112.75997983CS
12-2.08-49.52380952384.25.152.127657383.19650784CS
260.3419.10112359551.785.151.65507813.07855056CS
520.3821.83908045981.745.151.163863542.66389501CS
1561.7385455.7011795540.38156.240.24863102.06520875CS
260-0.06-2.752293577982.186.240.27949571.65258133CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UPCUniverse Pharmaceuticals Inc
$ 3.38
(221.90%)
93.72M
LIFWMSP Recovery Inc
$ 3.2461
(104.16%)
29.08M
GXAIGaxos ai Inc
$ 2.5801
(81.70%)
146.21M
SBETSharpLink Gaming Inc
$ 0.9116
(73.97%)
27.09M
HCTIHealthcare Triangle Inc
$ 1.165
(68.38%)
4.34M
ORISOriental Rise Holdings Ltd
$ 3.6833
(-93.42%)
27.58M
LICNLichen China Limited
$ 0.4895
(-76.91%)
186.02M
MYNAMynaric AG
$ 0.499246
(-64.59%)
3.62M
CEROCERo Therapeutics Holdings Inc
$ 0.1146
(-40.16%)
38.21M
BTCTBTC Digital Ltd
$ 10.50
(-32.95%)
3.31M
SMXSMX Security Matters Public Company
$ 0.4879
(64.06%)
448.58M
SOUNSoundHound AI Inc
$ 15.01
(12.60%)
218.94M
NVDANVIDIA Corporation
$ 142.44
(-1.81%)
187.57M
LICNLichen China Limited
$ 0.4895
(-76.91%)
186.02M
SVMHSRIVARU Holding Ltd
$ 0.0293
(-16.29%)
162.46M

RMTI Discussion

View Posts
glenn1919 glenn1919 4 weeks ago
RMTI........................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
RMTI.......................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
RMTI.......................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 4 months ago
RMTI..................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
RMTI.............................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 9 months ago
RMTI..........................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 9 months ago
RMTI............................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
triannual triannual 10 months ago
Price targets are as low as $5. I'm in @ $1.22. The quarterly numbers have gotten better. I guess we will know on March 21st.Good luck
👍️ 1
4Godnwv 4Godnwv 10 months ago
This thing has not been healthy in a while. I lost money on it last year, not sure why I’m even looking at it again. It took another major hit when they lowered guidance in January. The chart looks interesting, but charts don’t run on smoke and mirrors, they need material events to cause them to change directions. Watching - 4God
πŸ‘οΈ0
triannual triannual 10 months ago
Press Release: Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024.
The numbers better be really good. If not it's lights out. They will end up on the OTC. GLTA
πŸ‘οΈ0
triannual triannual 10 months ago
In @ $1.22
πŸ‘οΈ0
4Godnwv 4Godnwv 1 year ago
Recent news has stopped the bleeding. Expect Q3 numbers to lift the ppps here.
πŸ‘οΈ0
4Godnwv 4Godnwv 1 year ago
This thing got taken to the chopping block, but HC Wainwright may have pulled its bacon out of the fire.
πŸ‘οΈ0
willlbone willlbone 1 year ago
Seems like they might dump 10 million shares at $1.39.
πŸ‘οΈ0
Triple nickle Triple nickle 2 years ago
They beat estimates by almost double
Impressive outcome
πŸ‘οΈ0
Jayzp Jayzp 2 years ago
rmti vs ther

Ther can be big,with good news

https://www.prnewswire.com/news-releases/theralink-acquires-exclusive-landmark-immunotherapy-patent-including-biomarker-from-vanderbilt-university-301787847.html
πŸ‘οΈ0
tw0122 tw0122 2 years ago
Going up quick
πŸ‘οΈ0
makinezmoney makinezmoney 2 years ago
$RMTI: Shes havng a nice day today.... now $1.30


Nice run up there on the daily chart



GO $RMTI
πŸ‘οΈ0
GTF GTF 2 years ago
New ceo trying to get back to basics...get the biz profitable without relying on Triferic.
πŸ‘οΈ0
duderaja duderaja 3 years ago
Correct me if I'm wrong, but after the r/s the price should be 2.37 and it's 2.02 in pre-market which means it has dropped .35 in pre-market.
πŸ‘οΈ0
Triple nickle Triple nickle 3 years ago
Premarket looks promising
πŸ‘οΈ0
willlbone willlbone 3 years ago
Rock Bottom.
πŸ‘οΈ0
TSCTOlson TSCTOlson 3 years ago
$RMTI is scheduled to present at Aegis Virtual Conference, on Wednesday, February 23rd at 1:30 - 2:00 PM ET.
https://ih.advfn.com/stock-market/NASDAQ/rockwell-medical-RMTI/stock-news/87292951/rockwell-medical-inc-to-present-at-aegis-virtual
πŸ‘οΈ0
instock58 instock58 3 years ago
RMTI NEWS " Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea
https://finance.yahoo.com/news/rockwell-medical-announces-regulatory-approval-141500983.html

UP 1% and starting to rise...News just our 25 mins ago...
Heavy Volume Picking up ...becoming heavier..

https://finance.yahoo.com/quote/RMTI?p=RMTI


Finviz
https://finviz.com/quote.ashx?t=RMTI


TradingView Buy Rated
https://www.tradingview.com/symbols/NASDAQ-RMTI/


$RMTI




πŸ‘οΈ0
JetBlueJason JetBlueJason 3 years ago
Agreed....
Needs some news to sustain it.

Murocman
πŸ‘οΈ0
murocman murocman 3 years ago
Needs some news to sustain it.

Murocman
πŸ‘οΈ0
JetBlueJason JetBlueJason 3 years ago
Moving North for sure $$$$$$
$RMTI
πŸ‘οΈ0
TSCTOlson TSCTOlson 3 years ago
$RMTI will have huge breakout from here, I think
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 3 years ago
We be going North $$$$$:) air !!!!
πŸ‘οΈ0
Bigbruin Bigbruin 3 years ago
Good morning from miami fla
Why is this moving up anyone ?
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 3 years ago
Merry Christmas $$$$$$$:)
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
https://finance.yahoo.com/news/rockwell-medical-study-demonstrates-no-210100032.html

https://ih.advfn.com/stock-market/NASDAQ/rockwell-medical-RMTI/stock-news/86578594/rockwell-medical-study-demonstrates-no-drug-drug-i
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
A live webcast of the call will be available under "Events & Presentations" in the Investor section of the Company's website, https://ir.rockwellmed.com/. An archived webcast will be available on the Company's website approximately two hours after the event and will be available for 30 days.

To submit questions in advance, please email your questions to invest@rockwellmed.com.

$RMTI
πŸ‘οΈ0
budfoxfun budfoxfun 3 years ago
$RMTI Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021 https://finance.yahoo.com/news/rockwell-medical-inc-report-second-110000902.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @Yahoo
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
$RMTI News July 29, 2021

Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021
https://finance.yahoo.com/news/rockwell-medical-inc-report-second-110000902.html
πŸ‘οΈ0
budfoxfun budfoxfun 3 years ago
Green heading into the close!

RMTI
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
$RMTI trading at approximately 30% of its 10-day average volume...but it's trading green.
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
$RMTI will be able to tap into a largely under serviced patient pool...
πŸ‘οΈ0
budfoxfun budfoxfun 3 years ago
$RMTI announced that it has submitted a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (FDA) in support of its proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC), designed for the treatment of iron deficiency anemia and maintenance of hemoglobin in patients receiving infusion therapy in the home setting.

Home infusion represents a large and rapidly growing segment of healthcare. Many patient groups requiring home infusion therapies suffer from chronic diseases that are associated with a high incidence of iron deficiency and anemia. For example, it is estimated that 40%-55% of all home parenteral nutrition patients are iron deficient. Current treatment patterns can be inadequate for patients on home infusion therapy with iron deficiency anemia, causing them to suffer extreme fatigue and can result in serious health risks, such as, poor immune function and heart failure.
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
PRODUCING AND DELIVERING HEMODIALYSIS CONCENTRATES AND ANCILLARY PRODUCTS TO DIALYSIS PROVIDERS

Rockwell Medical, $RMTI, is an innovative leader in producing and delivering hemodialysis concentrates (solutions and powders) along with related ancillary products to dialysis providers located throughout the U.S. and abroad.

Rockwell Medical is dedicated to providing the hemodialysis community with the highest quality products supported by the most reliable delivery service in the industry. Rockwell has multiple manufacturing locations throughout the United States to ensure fast and efficient delivery of our products. The company adheres to Good Manufacturing Practices (GMPs) and to the Association for Advancement of Medical Instrumentation (AAMI) standards in our manufacturing, ensuring a high-quality hemodialysate known throughout the industry for safety and excellence.

Our customer service department is dedicated to the fundamental principle that our customers are the most important part of our business. Our representatives strive to provide the highest level of courtesy and efficiency to our customers. Rockwell Medical is an independent supplier that does not own or operate dialysis clinics. Our focus is on providing customers with quality dialysis products.

https://www.rockwellmed.com/hemodialysis-concentrates/supporting-dialysis-providers/
πŸ‘οΈ0
budfoxfun budfoxfun 3 years ago
$RMTI Rockwell Medical is a commercial-stage biopharmaceutical company developing and commercializing its next-generation parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC), which has the potential to lead transformative treatments for iron deficiency in multiple disease states, reduce healthcare costs and improve patients’ lives.

The Company has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform. The Company is developing FPC for the treatment of iron deficiency in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting, a large and rapidly growing segment of healthcare, and where these patients suffer from chronic diseases associated with high incidence of iron deficiency and anemia.

In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States. For more information, visit www.RockwellMed.com.
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
Once we see updates from the FDA on this, $RMTI will see a great run...
πŸ‘οΈ0
budfoxfun budfoxfun 3 years ago
β€œThis is an important step for Rockwell Medical and home infusion patients as we believe that FPC is uniquely suited to address this important unmet clinical need,” said Russell Ellison, M.D., President and Chief Executive Officer of Rockwell Medical. β€œWe expect to finalize our Phase 2 clinical study design and protocol with the advice and guidance of the FDA.”

RMTI
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
I found this page of the website interesting and informative, to help me understand why this technology is so special.

https://www.rockwellmed.com/our-technology/technology-platform/

PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY
Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).
πŸ‘οΈ0
budfoxfun budfoxfun 3 years ago
$RMTI a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it has submitted a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (FDA) in support of its proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC), designed for the treatment of iron deficiency anemia and maintenance of hemoglobin in patients receiving infusion therapy in the home setting.

Home infusion represents a large and rapidly growing segment of healthcare. Many patient groups requiring home infusion therapies suffer from chronic diseases that are associated with a high incidence of iron deficiency and anemia. For example, it is estimated that 40%-55% of all home parenteral nutrition patients are iron deficient. Current treatment patterns can be inadequate for patients on home infusion therapy with iron deficiency anemia, causing them to suffer extreme fatigue and can result in serious health risks, such as, poor immune function and heart failure.
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
Agreed, the $RTMI volume has decreased but the price action has been steady.
πŸ‘οΈ0
budfoxfun budfoxfun 3 years ago
Nice support at these levels!

RMTI
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
It's an interesting new technology...$RMTI

In addition, FPC iron is delivered regardless of other underlying conditions which might otherwise block the release of iron. Some of the challenges of managing iron in sick patients, including inflammation, hepcidin block, and functional iron deficiency, can be overcome with FPC due to its ability to provide bioavailable iron.

FPC is highly soluble in water and, therefore, can be formulated for parenteral administration either by the dialysis solution or intravenously. As a result, this novel approach to iron management has the potential for application in the treatment of anemia in many disease states.
πŸ‘οΈ0
ProfitScout ProfitScout 3 years ago
The RMTI approach to anemia treatment is a clear advancement and holds great promise for improving the lives of millions of people who suffer from this problem around the world.

From the company website:

PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY

Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).

Read more here:
https://www.rockwellmed.com/our-technology/technology-platform/
πŸ‘οΈ0
BlazingStocks BlazingStocks 3 years ago
$RMTI volume right around 20% of its 10-day average volume but trading GREEN!
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock